Suche senden
Hochladen
Module 7 prevention of hiv
•
Als PPT, PDF herunterladen
•
1 gefällt mir
•
321 views
D
David Ngogoyo
Folgen
Diashow-Anzeige
Melden
Teilen
Diashow-Anzeige
Melden
Teilen
1 von 14
Jetzt herunterladen
Empfohlen
gnm 3rd year chn
Duties and responsbilities of
Duties and responsbilities of
Kalinga Institute of Medical Sciences
The slideshow includes overview of EU project proposal preparation process. It is specific to Erasmus+ Key Action 2 - Strategic partnerships. Proposal preparation process for other calls may vary.
EU project proposal preparation process
EU project proposal preparation process
Tomislav Rozman
Kai Tullius, Policy Officer from DG Energy discusses the EU Project Network at the Global CCS Institute Member Meeting
EU Project Network - 8 May 2012
EU Project Network - 8 May 2012
Global CCS Institute
Apec workshop 2 presentation 7 2 apec workshop mexico 7 eu ccs demo network
Apec workshop 2 presentation 7 2 apec workshop mexico 7 eu ccs demo network
Global CCS Institute
“Advanced Fossil Energy Technologies” Southern Company Perspectives on Energy R&D
Atlantic Council - Randall Rush
Atlantic Council - Randall Rush
Global CCS Institute
CONSOL Energy R&D – Steven Winberg, Vice President – Global CCS Institute Reg...
CONSOL Energy R&D – Steven Winberg, Vice President – Global CCS Institute Reg...
Global CCS Institute
perio
Risk factors
Risk factors
SupriyoGhosh15
Syndromic management of sexually transmitted infections
RTIs-STIs Dr. Suraj Chawla
RTIs-STIs Dr. Suraj Chawla
Suraj Chawla
Empfohlen
gnm 3rd year chn
Duties and responsbilities of
Duties and responsbilities of
Kalinga Institute of Medical Sciences
The slideshow includes overview of EU project proposal preparation process. It is specific to Erasmus+ Key Action 2 - Strategic partnerships. Proposal preparation process for other calls may vary.
EU project proposal preparation process
EU project proposal preparation process
Tomislav Rozman
Kai Tullius, Policy Officer from DG Energy discusses the EU Project Network at the Global CCS Institute Member Meeting
EU Project Network - 8 May 2012
EU Project Network - 8 May 2012
Global CCS Institute
Apec workshop 2 presentation 7 2 apec workshop mexico 7 eu ccs demo network
Apec workshop 2 presentation 7 2 apec workshop mexico 7 eu ccs demo network
Global CCS Institute
“Advanced Fossil Energy Technologies” Southern Company Perspectives on Energy R&D
Atlantic Council - Randall Rush
Atlantic Council - Randall Rush
Global CCS Institute
CONSOL Energy R&D – Steven Winberg, Vice President – Global CCS Institute Reg...
CONSOL Energy R&D – Steven Winberg, Vice President – Global CCS Institute Reg...
Global CCS Institute
perio
Risk factors
Risk factors
SupriyoGhosh15
Syndromic management of sexually transmitted infections
RTIs-STIs Dr. Suraj Chawla
RTIs-STIs Dr. Suraj Chawla
Suraj Chawla
thanks for Ms Sumita Das faculty college of nursing Aiims new delhi for her duide and co_operation
18.epidemiology
18.epidemiology
sajjan kapuria
Demography, epidemiology and non-communicable diseases I/1. Demography in public health, basic demographic indicators. Demographic transition. Age-sex distribution, crude birth and death rates, fertility, migration. Standardization. I/2. Special fields of mortality: age-related mortality, gender-specific mortality. Infant mortality, perinatal mortality, maternal mortality. Life expectancy (at birth), description of international situation. I/3. Definition of epidemiology, data sources for epidemiology, measuring health status and mortality, incidence, prevalence. Descriptive and ecological studies. I/4. Analytic epidemiology .: cohort studies, absolute, relative and attributable risk; casecontrol studies, odds and odds ratios. Experimental studies in epidemiology I/5. Screening and validation of screening tests; sensitivity, specificity, predictive value. I/6. Epidemiology and prevention of cardiovascular diseases .
Demography, epidemiology and non-communicable diseases I1. Demograp.docx
Demography, epidemiology and non-communicable diseases I1. Demograp.docx
raelenehqvic
Ppt reproductive alterations exam review
Ppt reproductive alterations exam review
hannaspicer
This lecture was given as a part of the Introduction to Epidemiology & Community Medicine Course given for third-year medical students.
Epcm Introduction to Seminars in epidemiology course
Epcm Introduction to Seminars in epidemiology course
Dr Ghaiath Hussein
WHO statistics indicate that Over 340 million curable and many more incurable STIs occur each year among women worldwide and that Non-sexually-transmitted RTIs are even more common. Failure to diagnose and treat STIs/RTIs at an early stage may result into serious complications and consequences including infertility, fetal wastage, ectopic pregnancy, anogenital cancer, premature delivery, as well as neonatal and infant infections. Proper management of STIs/RTIs also reduce the maternal and infant mortality. STIs are also known to enhance the spread of HIV infection in communities. STIs/ RTIs also have negative socio economic impact that include, increase cost for health service, relationship/ marriage problems etc.
Final reproductive tract infectionspdf
Final reproductive tract infectionspdf
DR.RAKHSHINDA AMBREEN
Aids.ghana
Aids.ghana
Solomon
risk assessment tool
Risk assessment in periodontology
Risk assessment in periodontology
Dr. Mitali Thamke
Susan Newcomer, PhD, MS Health Scientist Administrator, Population Dynamics Eunice Kennedy Shriver National Institute of Child Health and Human Development
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
HopkinsCFAR
Bb
aids control pgram.pptNurses students jn
aids control pgram.pptNurses students jn
MANJUPAUL7
Susan Newcomer, NICHD
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
HopkinsCFAR
Presented by Fred Unger at the inception workshop for the 'Reducing Disease Risks and Improving Food Safety in Smallholder Pig Value Chains in Vietnam' project, Hanoi, August 14, 2012.
Animal health assessment (including zoonoses) in smallholder pig value chains
Animal health assessment (including zoonoses) in smallholder pig value chains
ILRI
NACO AIDS national programme , social and preventive medicine , spm , psm
National aids control programme
National aids control programme
Dr.Jatheesh Mohan
community
Community tyba (1).pptx
Community tyba (1).pptx
AyeshaSaleem423816
Global Health Final Exam Study Guide Spring 2015 GENERAL -know the difference between a VIRUS, a BACTERIUM and a PROTOZOAN -if you don’t know the specific name of the causative agent, but know which type of organism it is, you will get part marks -as you study each chapter, keep in mind how poverty can impact issues such as HIV/AIDS, disease in general, access to clean water, access to sanitation, nutrition, etc. and how these conditions/issues can lead to poverty) -arm yourself with specific examples illustrating this relationship -be able to interpret a graph that you have never seen before…look at axes to figure out what is being measured, be able to identify important trends, to interpret the data -practice understanding graphs we’ve gone over in class… INTRODUCTION -be able to name a few low-income, middle-income and high-income countries -communicable vs non-communicable diseases -relative burden in high-income vs low-income countries -what are the 3 most populated countries? -differences between graphing absolute numbers of people affected vs percentage of the population affected -how % can mask large #s of people in need -define poverty (income / day) -define: -causative agent -infectious dose -host (primary vs secondary) -vector -reservoir -incubation period / latent period / infectious period -herd immunity vs ring immunity -modifiable vs unmodifiable risk factors -epidemiologic triad -primary / secondary / tertiary disease prevention (and examples of each) -quarantine vs isolation -zoonotic / nosocomial / person to person transmission *be able to use this terminology when you discuss specific diseases* Q1. Compare and contrast the leading causes of mortality in low-income countries vs high- income countries. Provide an explanation for these observed differences, and comment on the double-burden that will soon exist in low-income countries. GLOBAL BURDEN OF DISEASE -data -types of data important for global health assessments -what are they used for? -challenges in acquisition -morbidity vs mortality -how changes in mortality can affect morbidity -rates vs absolute numbers -disease-specific? -incidence vs prevalence -screening and diagnosis -sensitivity -specificity -gold standard vs rapid tests -investigative studies (know these in very GENERAL terms) -correlational -case studies -cross-sectional study -observational -intervention -causality -confounding variables -randomization -blinding (single vs double-blind studies) -healthy life expectancy (HALE) vs life expectancy (LE) -QALYs -how to measure? -used for? -limitations -DALYs -how to measure? -used for? -age weighting -limitations Q1. Compare and contrast quality-adjusted life years (QALYs) and disability-adjusted life years (DALYs). What is the relationship between these 2 measurements? SOCIOECONOMICS AND HEALTH -what is the link bet.
Global Health Final Exam Study Guide Spring 2015 GENERAL.docx
Global Health Final Exam Study Guide Spring 2015 GENERAL.docx
budbarber38650
Personalized Medicine – From Theory to Practice as presented by keynote speaker Ralph Snyderman, MD; Director of the Center for Research on Prospective Health Care, James B. Duke Professor of Medicine, Chancellor Emeritus, Duke University
Personalized Medicine – From Theory to Practice
Personalized Medicine – From Theory to Practice
The Ohio State University Wexner Medical Center
Sexual health
Sexual Health and STIs including HIV.pdf
Sexual Health and STIs including HIV.pdf
NathanDanielgashahun
this slide describe completely about National AIDS Control Programme and schemes affiliated with it.
National AIDS Control Programme
National AIDS Control Programme
Dr.Virender pal Singh
This Ppt is about Epidemiology and objectives of Epidemiology and approach of Epidemiology
Epidemiological Approach to Disease and Intervention
Epidemiological Approach to Disease and Intervention
Muhammad Rafique
Task Details What do we know about COVID-19 risk factors? What have we learned from epidemiological studies? Specifically, we want to know what the literature reports about: Data on potential risks factors Smoking, pre-existing pulmonary disease Co-infections (determine whether co-existing respiratory/viral infections make the virus more transmissible or virulent) and other co-morbidities Neonates and pregnant women Socio-economic and behavioral factors to understand the economic impact of the virus and whether there were differences. Transmission dynamics of the virus, including the basic reproductive number, incubation period, serial interval, modes of transmission and environmental factors Severity of disease, including risk of fatality among symptomatic hospitalized patients, and high-risk patient groups Susceptibility of populations Public health mitigation measures that could be effective for control .
Task Details What do we know about COVID-19 risk factors What h.docx
Task Details What do we know about COVID-19 risk factors What h.docx
josies1
State of the science halkitis
State of the science halkitis
healthhiv
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
David Ngogoyo
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
David Ngogoyo
Weitere ähnliche Inhalte
Ähnlich wie Module 7 prevention of hiv
thanks for Ms Sumita Das faculty college of nursing Aiims new delhi for her duide and co_operation
18.epidemiology
18.epidemiology
sajjan kapuria
Demography, epidemiology and non-communicable diseases I/1. Demography in public health, basic demographic indicators. Demographic transition. Age-sex distribution, crude birth and death rates, fertility, migration. Standardization. I/2. Special fields of mortality: age-related mortality, gender-specific mortality. Infant mortality, perinatal mortality, maternal mortality. Life expectancy (at birth), description of international situation. I/3. Definition of epidemiology, data sources for epidemiology, measuring health status and mortality, incidence, prevalence. Descriptive and ecological studies. I/4. Analytic epidemiology .: cohort studies, absolute, relative and attributable risk; casecontrol studies, odds and odds ratios. Experimental studies in epidemiology I/5. Screening and validation of screening tests; sensitivity, specificity, predictive value. I/6. Epidemiology and prevention of cardiovascular diseases .
Demography, epidemiology and non-communicable diseases I1. Demograp.docx
Demography, epidemiology and non-communicable diseases I1. Demograp.docx
raelenehqvic
Ppt reproductive alterations exam review
Ppt reproductive alterations exam review
hannaspicer
This lecture was given as a part of the Introduction to Epidemiology & Community Medicine Course given for third-year medical students.
Epcm Introduction to Seminars in epidemiology course
Epcm Introduction to Seminars in epidemiology course
Dr Ghaiath Hussein
WHO statistics indicate that Over 340 million curable and many more incurable STIs occur each year among women worldwide and that Non-sexually-transmitted RTIs are even more common. Failure to diagnose and treat STIs/RTIs at an early stage may result into serious complications and consequences including infertility, fetal wastage, ectopic pregnancy, anogenital cancer, premature delivery, as well as neonatal and infant infections. Proper management of STIs/RTIs also reduce the maternal and infant mortality. STIs are also known to enhance the spread of HIV infection in communities. STIs/ RTIs also have negative socio economic impact that include, increase cost for health service, relationship/ marriage problems etc.
Final reproductive tract infectionspdf
Final reproductive tract infectionspdf
DR.RAKHSHINDA AMBREEN
Aids.ghana
Aids.ghana
Solomon
risk assessment tool
Risk assessment in periodontology
Risk assessment in periodontology
Dr. Mitali Thamke
Susan Newcomer, PhD, MS Health Scientist Administrator, Population Dynamics Eunice Kennedy Shriver National Institute of Child Health and Human Development
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
HopkinsCFAR
Bb
aids control pgram.pptNurses students jn
aids control pgram.pptNurses students jn
MANJUPAUL7
Susan Newcomer, NICHD
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
HopkinsCFAR
Presented by Fred Unger at the inception workshop for the 'Reducing Disease Risks and Improving Food Safety in Smallholder Pig Value Chains in Vietnam' project, Hanoi, August 14, 2012.
Animal health assessment (including zoonoses) in smallholder pig value chains
Animal health assessment (including zoonoses) in smallholder pig value chains
ILRI
NACO AIDS national programme , social and preventive medicine , spm , psm
National aids control programme
National aids control programme
Dr.Jatheesh Mohan
community
Community tyba (1).pptx
Community tyba (1).pptx
AyeshaSaleem423816
Global Health Final Exam Study Guide Spring 2015 GENERAL -know the difference between a VIRUS, a BACTERIUM and a PROTOZOAN -if you don’t know the specific name of the causative agent, but know which type of organism it is, you will get part marks -as you study each chapter, keep in mind how poverty can impact issues such as HIV/AIDS, disease in general, access to clean water, access to sanitation, nutrition, etc. and how these conditions/issues can lead to poverty) -arm yourself with specific examples illustrating this relationship -be able to interpret a graph that you have never seen before…look at axes to figure out what is being measured, be able to identify important trends, to interpret the data -practice understanding graphs we’ve gone over in class… INTRODUCTION -be able to name a few low-income, middle-income and high-income countries -communicable vs non-communicable diseases -relative burden in high-income vs low-income countries -what are the 3 most populated countries? -differences between graphing absolute numbers of people affected vs percentage of the population affected -how % can mask large #s of people in need -define poverty (income / day) -define: -causative agent -infectious dose -host (primary vs secondary) -vector -reservoir -incubation period / latent period / infectious period -herd immunity vs ring immunity -modifiable vs unmodifiable risk factors -epidemiologic triad -primary / secondary / tertiary disease prevention (and examples of each) -quarantine vs isolation -zoonotic / nosocomial / person to person transmission *be able to use this terminology when you discuss specific diseases* Q1. Compare and contrast the leading causes of mortality in low-income countries vs high- income countries. Provide an explanation for these observed differences, and comment on the double-burden that will soon exist in low-income countries. GLOBAL BURDEN OF DISEASE -data -types of data important for global health assessments -what are they used for? -challenges in acquisition -morbidity vs mortality -how changes in mortality can affect morbidity -rates vs absolute numbers -disease-specific? -incidence vs prevalence -screening and diagnosis -sensitivity -specificity -gold standard vs rapid tests -investigative studies (know these in very GENERAL terms) -correlational -case studies -cross-sectional study -observational -intervention -causality -confounding variables -randomization -blinding (single vs double-blind studies) -healthy life expectancy (HALE) vs life expectancy (LE) -QALYs -how to measure? -used for? -limitations -DALYs -how to measure? -used for? -age weighting -limitations Q1. Compare and contrast quality-adjusted life years (QALYs) and disability-adjusted life years (DALYs). What is the relationship between these 2 measurements? SOCIOECONOMICS AND HEALTH -what is the link bet.
Global Health Final Exam Study Guide Spring 2015 GENERAL.docx
Global Health Final Exam Study Guide Spring 2015 GENERAL.docx
budbarber38650
Personalized Medicine – From Theory to Practice as presented by keynote speaker Ralph Snyderman, MD; Director of the Center for Research on Prospective Health Care, James B. Duke Professor of Medicine, Chancellor Emeritus, Duke University
Personalized Medicine – From Theory to Practice
Personalized Medicine – From Theory to Practice
The Ohio State University Wexner Medical Center
Sexual health
Sexual Health and STIs including HIV.pdf
Sexual Health and STIs including HIV.pdf
NathanDanielgashahun
this slide describe completely about National AIDS Control Programme and schemes affiliated with it.
National AIDS Control Programme
National AIDS Control Programme
Dr.Virender pal Singh
This Ppt is about Epidemiology and objectives of Epidemiology and approach of Epidemiology
Epidemiological Approach to Disease and Intervention
Epidemiological Approach to Disease and Intervention
Muhammad Rafique
Task Details What do we know about COVID-19 risk factors? What have we learned from epidemiological studies? Specifically, we want to know what the literature reports about: Data on potential risks factors Smoking, pre-existing pulmonary disease Co-infections (determine whether co-existing respiratory/viral infections make the virus more transmissible or virulent) and other co-morbidities Neonates and pregnant women Socio-economic and behavioral factors to understand the economic impact of the virus and whether there were differences. Transmission dynamics of the virus, including the basic reproductive number, incubation period, serial interval, modes of transmission and environmental factors Severity of disease, including risk of fatality among symptomatic hospitalized patients, and high-risk patient groups Susceptibility of populations Public health mitigation measures that could be effective for control .
Task Details What do we know about COVID-19 risk factors What h.docx
Task Details What do we know about COVID-19 risk factors What h.docx
josies1
State of the science halkitis
State of the science halkitis
healthhiv
Ähnlich wie Module 7 prevention of hiv
(20)
18.epidemiology
18.epidemiology
Demography, epidemiology and non-communicable diseases I1. Demograp.docx
Demography, epidemiology and non-communicable diseases I1. Demograp.docx
Ppt reproductive alterations exam review
Ppt reproductive alterations exam review
Epcm Introduction to Seminars in epidemiology course
Epcm Introduction to Seminars in epidemiology course
Final reproductive tract infectionspdf
Final reproductive tract infectionspdf
Aids.ghana
Aids.ghana
Risk assessment in periodontology
Risk assessment in periodontology
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
aids control pgram.pptNurses students jn
aids control pgram.pptNurses students jn
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
Leaping the Hurdles and Navigating the Maze: Understanding the NIH
Animal health assessment (including zoonoses) in smallholder pig value chains
Animal health assessment (including zoonoses) in smallholder pig value chains
National aids control programme
National aids control programme
Community tyba (1).pptx
Community tyba (1).pptx
Global Health Final Exam Study Guide Spring 2015 GENERAL.docx
Global Health Final Exam Study Guide Spring 2015 GENERAL.docx
Personalized Medicine – From Theory to Practice
Personalized Medicine – From Theory to Practice
Sexual Health and STIs including HIV.pdf
Sexual Health and STIs including HIV.pdf
National AIDS Control Programme
National AIDS Control Programme
Epidemiological Approach to Disease and Intervention
Epidemiological Approach to Disease and Intervention
Task Details What do we know about COVID-19 risk factors What h.docx
Task Details What do we know about COVID-19 risk factors What h.docx
State of the science halkitis
State of the science halkitis
Mehr von David Ngogoyo
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
David Ngogoyo
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
David Ngogoyo
Unit 2 mtct and prevention strategies
Unit 2 mtct and prevention strategies
David Ngogoyo
Unit 4 care of the hiv infected mother
Unit 4 care of the hiv infected mother
David Ngogoyo
Unit 6 infant feeding and pmtct
Unit 6 infant feeding and pmtct
David Ngogoyo
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
David Ngogoyo
Unit 5 drug regimens for pmtct
Unit 5 drug regimens for pmtct
David Ngogoyo
Unit 3 counseling for pmtct
Unit 3 counseling for pmtct
David Ngogoyo
Module 10 hiv and aids legal and ethical issues gsn
Module 10 hiv and aids legal and ethical issues gsn
David Ngogoyo
Module 10 hiv-aids legal & ethical issues
Module 10 hiv-aids legal & ethical issues
David Ngogoyo
Module 9 adherence & psychosocial counselling
Module 9 adherence & psychosocial counselling
David Ngogoyo
Module 7 prevention of hiv
Module 7 prevention of hiv
David Ngogoyo
Module 5 comprehensive care gsn
Module 5 comprehensive care gsn
David Ngogoyo
Module 8 nutrition and hiv 2
Module 8 nutrition and hiv 2
David Ngogoyo
Module 4 hiv infection & art in children
Module 4 hiv infection & art in children
David Ngogoyo
Participants workbook
Participants workbook
David Ngogoyo
Participants notes
Participants notes
David Ngogoyo
Indicators manual
Indicators manual
David Ngogoyo
Facilitators workbook
Facilitators workbook
David Ngogoyo
Facilitators guide
Facilitators guide
David Ngogoyo
Mehr von David Ngogoyo
(20)
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
Unit 2 mtct and prevention strategies
Unit 2 mtct and prevention strategies
Unit 4 care of the hiv infected mother
Unit 4 care of the hiv infected mother
Unit 6 infant feeding and pmtct
Unit 6 infant feeding and pmtct
Unit 1 hiv and reproductive health
Unit 1 hiv and reproductive health
Unit 5 drug regimens for pmtct
Unit 5 drug regimens for pmtct
Unit 3 counseling for pmtct
Unit 3 counseling for pmtct
Module 10 hiv and aids legal and ethical issues gsn
Module 10 hiv and aids legal and ethical issues gsn
Module 10 hiv-aids legal & ethical issues
Module 10 hiv-aids legal & ethical issues
Module 9 adherence & psychosocial counselling
Module 9 adherence & psychosocial counselling
Module 7 prevention of hiv
Module 7 prevention of hiv
Module 5 comprehensive care gsn
Module 5 comprehensive care gsn
Module 8 nutrition and hiv 2
Module 8 nutrition and hiv 2
Module 4 hiv infection & art in children
Module 4 hiv infection & art in children
Participants workbook
Participants workbook
Participants notes
Participants notes
Indicators manual
Indicators manual
Facilitators workbook
Facilitators workbook
Facilitators guide
Facilitators guide
Module 7 prevention of hiv
1.
PREVENTION OF HIV
INFECTION
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Jetzt herunterladen
![OBJECTIVES ,[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)